Regeneron Pharmaceuticals, Inc.
NASDAQ · Common stock
Close, Oct 16, 2026
Context across dimensions, not a rating
Counts ending at the latest intermediate swing low, 722.02 on Oct 5, 2026. 108 labelings tested, 82 broke a hard rule, 12+ remain.
Bar length is the zone's strength (a weighted count of relationships, not a probability). Select a zone to see what forms it.
4 relationships · strength 5.4 · Primary, Intermediate, Minor degrees
Intermediate degree · from the preferred count
The intermediate-degree scenario was held back
Its levels didn't pass Viridia's checks: invalidation over 25% away; invalidation over 8 ATR away; reward/risk outside 1–10. It's listed for review instead of shown.
Setups at other degrees:
Daily chart, as of Oct 16, 2026
Since the count's last pivot (722.02, Oct 5, 2026) price has moved +9.5%, the way the count expects.12 of 12 rule-valid counts expect the current move to be up.Weekly count: zigzag wave C ↑, same direction
Close call.The top two counts are within 4 points. Treat the structure as unresolved until one is invalidated.
Price is in wave C of a three-wave zigzag correction up.
A-B from 591.52, Jun 2, 2026
3 of 3 checks met
Price below this level breaks the count.
Wave C = 100% of wave A
4 Fibonacci relationships meet here.
Price is in wave 3 of a five-wave advance (impulse).
1-2 from 591.52, Jun 2, 2026
2 of 2 checks met
None.
Wave counts are built on these swings and each one passes every rule in the rulebook. They are ranked by how many guidelines they satisfy; the preferred and alternate counts are summarized above the chart.